A Breakthrough in Bioelectronic Connectivity

A significant hurdle in the field of bioelectronics has long been the trade-off between physical connections and wireless alternatives. Traditional exposed sockets often pose a high risk of microbial infection, while wireless charging systems are frequently too bulky for many medical applications. Researchers at the University of California, Irvine (UCI) have introduced a solution: the Implantable Bioelectronic Outlet (IBO), a device that remains safely beneath the skin and is accessed only when necessary.


How the Implantable Bioelectronic Outlet Works

The IBO functions as a versatile gateway, compatible with a wide range of medical implants, including neural interfaces, various sensors, stimulators, and internal battery systems. The device is constructed primarily from a porous, soft spongy plastic with pores approximately 150 micrometers in diameter. To facilitate electrical conductivity, these pores are coated with a thin polymer layer, and the entire structure is encased in a protective, insulating silicone rubber jacket.


As Hyung Joon Shim, a postdoctoral scholar in electrical engineering at UCI, explains, the device remains fully embedded under the dermis. Access is granted only through the insertion of a needle, which is withdrawn immediately after charging or data retrieval is complete.


Experimental Success and Performance

The research team has conducted extensive testing on animal models, demonstrating both efficiency and durability:

  • Data Transfer: In mouse and rat models, researchers achieved data transfer speeds of nearly 16 Mbps, reaching the hardware's maximum capacity.
  • Durability: The porous structure maintained integrity even after being subjected to more than 100 needle insertions.
  • Stability: Outlets implanted in mice showed no signs of degradation or physical complications over a period exceeding one year.
  • Functional Versatility: Experiments on pigs proved the system capable of delivering 20-microampere electrical pulses to stimulation implants over extended durations.

Safety and Future Considerations

Regarding the long-term viability of the technology, Jennifer Gelinas, associate professor of pediatrics and anatomy and neurobiology at UCI, noted: «Long-term safety is among the most critical requirements for any implantable technology.»


While the current needle access method is comparable to a standard injection, future iterations of the IBO may focus on improving patient comfort. Potential advancements include the use of topical anesthetics, thinner needles—since the device does not require a hollow channel for fluids—and specialized coatings to minimize inflammation. The research team emphasizes that further studies on tissue response and infection risks in repeated access scenarios are essential before moving toward clinical trials in humans.